Protein Expression Technology Market
Market Insights on Protein Expression Technology covering sales outlook, demand forecast & up-to-date key trends
Protein Expression Technology Market by Expression System (Insect Cell Expression System, Prokaryotic Expression System, Mammalian Expression System), by Product (Expression Vectors, Reagents), by Application (Drug Discovery, Protein Purification) & Region - Forecast 2022 - 2029
Protein Expression Technology Market Snapshot (2022-2029)
[210 Pages Report] Global protein expression technology market is set to experience a significant growth of 7.3% CAGR from 2022 to 2029, with an estimated market value of around US$ 2.4 Bn as of 2022.
Market Outlook:
|
Data Points |
Market Insights |
|
Market Value 2021 |
US$ 2.3 Bn |
|
Market Value 2029 |
US$ 3.97 Bn |
|
CAGR 2022-2029 |
7.3% |
|
Market Share of Top 5 Countries |
60.8% |
|
Key Market Players |
Lonza AG, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Inc, Agilent Technologies, Inc, QIAGEN N.V, Takara Bio, Inc, Fujifilm Diosynth Biotechnologies USA, Inc, Genscript Biotech Corporation, Promega Corporation, Hudson Robotics Inc, Lucigen Corporation, New England Biolabs, Inc, Merck Millipore, GeneCopoeia, Inc, Bioneer Corporation and Oxford Expression Technologies Ltd |
As per Future Market Insights’ projections, Mammalian Expression Systems hold a substantial share of over 38.2% in 2021 within the global protein expression technology market.
The high impact of emerging technologies such as proteomics is causing radial changes in the field of drug discovery as well as clinical research and diagnostics. As a result, end users in the life sciences arena are looking for complete integrated solutions.
The urgent trend in the protein expression technology market has been the formation of a broad partnership in the commercial sector as it is the best way to maximize opportunities as smaller companies can affiliate themselves with larger, more recognized suppliers.
Protein expression systems generally comprise of a minimal set of elements necessary for in-vitro protein translation and to aid quick research protocols without the hassles of additional gene-cloning step and tedious protein purification methods.
The rising demand for simpler, rapid and effective protein production methods is enhancing the applications of protein expression in R&D activities. Thereby, growing the demand in the protein expression technology market.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
7.24% |
|
H1, 2022 Projected |
7.26% |
|
H1, 2022 Outlook |
7.16% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 8 ↓ |
Licencing of biologics, and clinical outcomes of treatment are some of the dynamics which impact the market for protein expression technology. The market is subject to be influenced by macro, regulatory, and industrial factors. Designing of mammalian expression system models to reduce clinical costs is a key market developmental aspect.
According to FMI analysis, the protein expression technology market is expected to decline by 08 Basis Share Point (BPS) in H1-2022 (O) when compared with H1-2021. The variation observed between the BPS values in the market in H1, 2022 - outlook over H1, 2022 projected reflects a decline of 10 BPS units.
Industrial scalability for boosting protein yields inducing high up-front capital costs in mammalian and animal protein expression technology is a key element responsible for the reduction in the BPS value for the protein expression technology market.
Conversely, other market segments are expected to perform objectively and achieve lucrative growth prospects in the next half of projection period, owing to the development of plant expression platforms.
Sales Analysis Of Protein Expression Technology From 2014 To 2021 Vs Market Outlook For 2022 To 2029
The protein expression technology market holds nearly 40% of the overall US$ 5.7 Bn genome editing market in 2021. The historical value of CAGR displayed by the market is 6.5% from 2014-2021.
Ease of use and performance of protein expression systems makes it convenient for their incorporation into high throughput technological platforms for effective study outcomes in proteomics as well as biologics.
Protein expression systems, being open systems, permit the addition of varied natural and non-natural components into the reaction mixture and it may include elements for oxidation or reduction processes, chaperones, labelled amino acids, or detergents making it an appropriate choice for diverse proteomics studies.
Increasing number of proteomics and biologic study programs is also expected to boost demand for protein expression systems. Therefore, the introduction of such projects in future could serve as a highly profitable market opportunity for players in the protein expression technology market.
Conventional production of antibodies and antibody fragments have the drawbacks of being rather time-consuming and expensive. In recent years, efficient and potent protein synthesis systems have been developed. These systems have enhanced the antibody production pipeline, as these systems are able to mimic the pathway of antibody production in eukaryotic cells.
The market is expected to expand at a considerable growth rate over the next seven years at a CAGR of close to 7.3%.
What Are The Key Opportunities For Protein Expression Technology Manufacturers?
The global protein expression technology market is continually witnessing an opportunistic growth over factors including the shift in investments in the research practices within the fields of life sciences and biotechnology, gene editing being the most lucrative field presently.
In the regions of North America and Europe, the R&D investments within the field of biologics and their incorporated technological advancements is gaining traction. Emerging economies and regions such as South Asia, possess an abundant scale of skilled labour as well as the presence of qualified manpower with affordable cost of labour. This in turn allows the process of outsourced project development in biotechnological studies as well as product development.
Moreover, some government bodies in such regions have initiated provision of resources for backing up the growth of the local biotechnology industry. This solution often involves offering exemptions for R&D in terms of tax, providing improved budgets and funding, creating public and private conglomerates and attracting foreign direct investments.
In spite of the industry composing of numerous large and key players as well as several smaller companies, there are limited players which have complete emphasis on manufacturing as well as distributing of reagents for research and diagnostic uses. Most of the producers have diverse specializations and product offerings, with most key players linking research reagents and products with equipment, in-vitro diagnostics tools etc.
These factors together provide a lucrative prospect for the protein expression technology to gain higher importance over the period of forecasted years.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Are The Factors Restraining Demand For Protein Expression Technology?
One of the major holdups in the protein expression technology market is the low production volumes in the process. This limitation makes protein expression unbefitting for large industrial applications and is usually ideal in small R&D processes. The protein expression and purification is a gradual process which requires multiple steps such as cloning, expression, purification and analysis.
Since the process of protein expression is quiet, complicated and various steps in the entire process are not responsive to automation, it leads to poor clone survival, low expression levels, and protein degradation. Therefore, to sustain uniform workflow, highly trained professionals are required to carry out the complete workflow.
Although expression systems are well-recognized and validated for several life-threatening diseases, the high cost associated with these products, especially those used in clinical applications present a great challenge for market growth, especially in emerging economies in Asia Pacific.
There is an increasing inclination for superior products as they are of a higher quality than standard reagents. However, as applications evolve, the demand for newer products increases, which are at the higher end of the pricing spectrum compared to conventional expression systems. These factors conclusively present as restrictive factors for the growth of protein expression technology market.
Country-Wise Insights
What Makes the U.S. the Largest Market for Protein expression technology?
The U.S. dominates the North American region with a total market share of about 86.9% in 2021, and is projected to continue experiencing high growth throughout the forecast period. The growth in this region is established by the provision of grants as well as support policies established by the government.
These steps promote the research and development environment of the country, owing to the rising research using expression systems for development of proteins for products serving populations afflicted with the prevalence of diseases.
Why is Germany Considered a Lucrative Market for Protein expression technology in Western Europe?
Germany is set to exhibit a CAGR of nearly 8.2% in the Western Europe protein expression technology market during the forecast period. Academia in the region is bolstered through the availability of resources as well as technologies to understand disease pattern, biologics as well as driven models for controlled assessment of cure.
The high impact of the emerging technologies such as proteomics is causing radial changes in the field of drug discovery as well as clinical research and diagnostics. As a result, end users in the European life sciences arena are looking for the complete integrated solutions.
What Makes China an Emerging Market for Protein expression technology?
China holds 55.3% share in the APEJ market in 2021, and is projected to increase at a CAGR rate of 8.6% during the forecast period. China has markedly promoted studies including codon optimization with integration of deep learning to enhance the protein expression systems. This new wave technological applications induce the current stance that China upholds.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-Wise Insights
Which Protein expression system is Driving Market Growth?
Mammalian Expression Systems project a lucrative growth at a CAGR of 9.6% till the end of the forecast period, with a market share of about 38.2% in 2021, as they are systems of choice for studying the function of a particular protein in the most physiologically relevant environment, because it allows for the highest level of posttranslational processing and functional activity of the protein.
Which Product is Largely of Focus in the Protein expression technology Market?
Reagents hold a revenue share of 40.7% in 2021 and are projected to hold a share over the forecast period with the estimation being 42.4% as the reagents as well as kits are optimized for efficient, rapid and simplified transfection of mammalian cells, crucial for enhanced research outcomes.
Which Application in the Protein Expression Technology is Driving Market Growth?
Protein Therapeutics project a lucrative growth at a CAGR of 7.9% till the end of the forecast period, with a market share of about 43.0% in 2021, owing to the diverse applications of such systems over the conventional small molecule systems, thus improving efficacy as well as outcomes.
Which End User Benefits The Most by Employment of Protein expression technology?
Pharmaceutical Companies lead the protein expression technology market with about 37.6% market share in 2021. With the advanced development of product lines using protein expression technology, the distribution, as well as production processes in the pharmaceutical player environment leads to beneficial penetration into emerging geographies through regional tie-ups.
Competitive Landscape
The key players in the protein expression technology market are focusing on collaborations, territorial expansion, mergers, and acquisitions to increase share in the segment. Mergers and acquisitions help to grow their existing product portfolio and topographical reach.
For example, to fortify their life science business, Thermo Fisher Scientific Inc. acquired Life Technologies Corporation, which incorporates cutting edge proteomics and genomics innovations. Rising regulatory approval for biologics and technological advancements have prompted high demand for innovative products.
- In June 2021, Akara Bio Inc. announced that it has entered into a License and Supply Agreement with BioNTech Cell & Gene Therapies GmbH, Germany, under which Takara Bio grants BioNTech a commercial license to use applicable patents relating to RetroNectin®. Under this agreement, Takara Bio provides BioNTech with reliable supplies of RetroNectin®.
- In May 2020, GenScript Biotech announced CE-IVD approval for its Neutralizing Antibody Test kit of SARS-CoV-2 and COVID-19 diagnostic products.
Similarly, recent developments related to companies manufacturing protein expression technology products have been tracked by the team at Future Market Insights, which are available in the full report.
Report Scope As Per Protein Expression Technology Industry Analysis
|
Attribute |
Details |
|
Forecast Period |
2022-2029 |
|
Historical Data Available for |
2014-2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
North America, Latin America, Western Europe, Eastern Europe, Japan, APEJ and Middle East and Africa |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, Nordic, BENELUX, Poland, Russia, China, Japan, India, Australia, New Zealand, GCC Countries, and South Africa |
|
Key Market Segments Covered |
Expression Systems, Product, Application, End User and Region |
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Market Segments Covered In Protein Expression Technology Market Research
By Expression System :
- Insect Cell Expression System
- Prokaryotic Expression System
- Mammalian Expression System
- Yeast Expression System
- Other
By Product :
- Expression Vectors
- Reagents
- Competent Cells
- Instruments
By Application :
- Drug Discovery
- Protein Purification
- Protein Therapeutics
- Diseases Diagnostic & Monitoring
By End User :
- Biotechnology Companies
- Pharmaceutical Companies
- Contract Research Organisation
- Academic Research Institute
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- Japan
- APEJ
- Middle East and Africa (MEA)
Frequently Asked Questions
The global protein expression technology market is worth US$ 2.3 Bn at present, and is set to expand 1.6X over the next seven years.
The protein expression technology market is expected to reach US$ 3.97 Bn by the end of 2029, with sales revenue expected to register 7.3% CAGR.
Enhanced sales network and distribution channels and advancement and increase in research on proteomics are some of the key trends being witnessed in the protein expression technology market.
The U.S., China, Germany, U.K. and Canada are expected to drive demand in protein expression technology market.
North America is one of the key markets for protein expression technology, with the U.S. expected to account over 86.9% of the North American market during the forecast period.
Demand for protein expression technology in Western Europe is expected to register growth of 7.1% over the next seven years.
Lonza AG, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Inc, Agilent Technologies, Inc, QIAGEN N.V, Takara Bio, Inc, Fujifilm Diosynth Biotechnologies USA, Inc, Genscript Biotech Corporation, Promega Corporation, Hudson Robotics Inc, Lucigen Corporation, New England Biolabs, Inc, Merck Millipore, GeneCopoeia, Inc, Bioneer Corporation and Oxford Expression Technologies Ltd are the key exporters of protein expression technology market.
Table of Content
1. Executive Summary
1.1. Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Macro-Economic Factors
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity Analysis
3.1.4. Trends
3.1.5. Market Sizing Factors and Assumptions
4. Global Protein Expression Technology Market (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029
4.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
4.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
4.2.3. Market Value Comparison
5. Global Protein Expression Technology Market Analysis 2014-2021 and Forecast 2022-2029, by Expression System
5.1. Introduction / Key Findings
5.2. Historical Market Size (US$ Mn) Analysis By Expression System, 2014-2021
5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Expression System, 2022 - 2029
5.3.1. Insect Cell Expression System
5.3.2. Prokaryotic Expression System
5.3.3. Mammalian Expression System
5.3.4. Yeast Expression System
5.3.5. Other Expression System
5.4. Market Attractiveness Analysis By Expression System
6. Global Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029, by Product
6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis By Product, 2014-2021
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022 - 2029
6.3.1. Expression Vectors
6.3.2. Reagents
6.3.3. Competent Cells
6.3.4. Instruments
6.4. Market Attractiveness Analysis By Product
7. Global Protein Expression Technology Market Analysis 2014-2021 and Forecast 2022-2029, by Application
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Application, 2014-2021
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022 - 2029
7.3.1. Drug Discovery
7.3.2. Protein Purification
7.3.3. Protein Therapeutics
7.3.4. Diseases Diagnosis and Monitoring
7.4. Market Attractiveness Analysis By Application
8. Global Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029, by End User
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By End User, 2014-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022 - 2029
8.3.1. Biotechnology Companies
8.3.2. Pharmaceutical Companies
8.3.3. Contract Research Organisation
8.3.4. Academic Research Institutes
8.4. Market Attractiveness Analysis By End User
9. Global Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2021
9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2029
9.3.1. North America
9.3.2. Latin America
9.3.3. Western Europe
9.3.4. Eastern Europe
9.3.5. Asia-Pacific Excluding Japan
9.3.6. Japan
9.3.7. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029
10.1. Introduction
10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Product
10.3.3. By Expression System
10.3.4. By Application
10.3.5. By End User
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Product
10.4.3. By Expression System
10.4.4. By Application
10.4.5. By End User
11. Latin America Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
11.3.1. By Country
11.3.1.1. Mexico
11.3.1.2. Brazil
11.3.1.3. Rest of Latin America
11.3.2. By Product
11.3.3. By Expression System
11.3.4. By Application
11.3.5. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product
11.4.3. By Expression System
11.4.4. By Application
11.4.5. By End User
12. Western Europe Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. Italy
12.3.1.3. France
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. BENELUX
12.3.1.7. Rest of Western Europe
12.3.2. By Product
12.3.3. By Expression System
12.3.4. By Application
12.3.5. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Expression System
12.4.4. By Application
12.4.5. By End User
13. Eastern Europe Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
13.3.1. By Country
13.3.1.1. Russia
13.3.1.2. Poland
13.3.1.3. Rest of Eastern Europe
13.3.2. By Product
13.3.3. By Expression System
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Expression System
13.4.4. By Application
13.4.5. By End User
14. APEJ Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
14.3.1. By Country
14.3.1.1. China
14.3.1.2. India
14.3.1.3. Australia & New Zealand
14.3.1.4. ASEAN
14.3.1.5. Rest of APEJ
14.3.2. By Product
14.3.3. By Expression System
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Expression System
14.4.4. By Application
14.4.5. By End User
15. Japan Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
15.3.1. By Product
15.3.2. By Expression System
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Expression System
15.4.3. By Application
15.4.4. By End User
16. Middle East and Africa Protein Expression Technology Market Analysis 2014-2021and Forecast 2022-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. South Africa
16.3.1.3. Rest of MEA
16.3.2. By Product
16.3.3. By Expression System
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Expression System
16.4.4. By Application
16.4.5. By End User
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competition Deep Dive
17.2.1. Lonza AG
17.2.1.1. Overview
17.2.1.2. Product Portfolio
17.2.1.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.1.4. Sales Footprint
17.2.1.5. Strategy Overview
17.2.1.5.1. Marketing Strategy
17.2.1.5.2. Product Strategy
17.2.1.5.3. Route of Administration Strategy
17.2.2. Bio-Rad Laboratories, Inc
17.2.2.1. Overview
17.2.2.2. Product Portfolio
17.2.2.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.2.4. Sales Footprint
17.2.2.5. Strategy Overview
17.2.2.5.1. Marketing Strategy
17.2.2.5.2. Product Strategy
17.2.2.5.3. Route of Administration Strategy
17.2.3. Thermo Fisher Scientific, Inc
17.2.3.1. Overview
17.2.3.2. Product Portfolio
17.2.3.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.3.4. Sales Footprint
17.2.3.5. Strategy Overview
17.2.3.5.1. Marketing Strategy
17.2.3.5.2. Product Strategy
17.2.3.5.3. Route of Administration Strategy
17.2.4. Agilent Technologies, Inc
17.2.4.1. Overview
17.2.4.2. Product Portfolio
17.2.4.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.4.4. Sales Footprint
17.2.4.5. Strategy Overview
17.2.4.5.1. Marketing Strategy
17.2.4.5.2. Product Strategy
17.2.4.5.3. Route of Administration Strategy
17.2.5. QIAGEN N.V
17.2.5.1. Overview
17.2.5.2. Product Portfolio
17.2.5.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.5.4. Sales Footprint
17.2.5.5. Strategy Overview
17.2.5.5.1. Marketing Strategy
17.2.5.5.2. Product Strategy
17.2.5.5.3. Route of Administration Strategy
17.2.6. Takara Bio, Inc
17.2.6.1. Overview
17.2.6.2. Product Portfolio
17.2.6.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.6.4. Sales Footprint
17.2.6.5. Strategy Overview
17.2.6.5.1. Marketing Strategy
17.2.6.5.2. Product Strategy
17.2.6.5.3. Route of Administration Strategy
17.2.7. Fujifilm Diosynth Biotechnologies USA, Inc
17.2.7.1. Overview
17.2.7.2. Product Portfolio
17.2.7.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.7.4. Sales Footprint
17.2.7.5. Strategy Overview
17.2.7.5.1. Marketing Strategy
17.2.7.5.2. Product Strategy
17.2.7.5.3. Route of Administration Strategy
17.2.8. Genscript Biotech Corporation
17.2.8.1. Overview
17.2.8.2. Product Portfolio
17.2.8.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.8.4. Sales Footprint
17.2.8.5. Strategy Overview
17.2.8.5.1. Marketing Strategy
17.2.8.5.2. Product Strategy
17.2.8.5.3. Route of Administration Strategy
17.2.9. Promega Corporation
17.2.9.1. Overview
17.2.9.2. Product Portfolio
17.2.9.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.9.4. Sales Footprint
17.2.9.5. Strategy Overview
17.2.9.5.1. Marketing Strategy
17.2.9.5.2. Product Strategy
17.2.9.5.3. Route of Administration Strategy
17.2.10. Hudson Robotics Inc
17.2.10.1. Overview
17.2.10.2. Product Portfolio
17.2.10.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.10.4. Sales Footprint
17.2.10.5. Strategy Overview
17.2.10.5.1. Marketing Strategy
17.2.10.5.2. Product Strategy
17.2.10.5.3. Route of Administration Strategy
17.2.11. Lucigen Corporation
17.2.11.1. Overview
17.2.11.2. Product Portfolio
17.2.11.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.11.4. Sales Footprint
17.2.11.5. Strategy Overview
17.2.11.5.1. Marketing Strategy
17.2.11.5.2. Product Strategy
17.2.11.5.3. Route of Administration Strategy
17.2.12. New England Biolabs, Inc
17.2.12.1. Overview
17.2.12.2. Product Portfolio
17.2.12.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.12.4. Sales Footprint
17.2.12.5. Strategy Overview
17.2.12.5.1. Marketing Strategy
17.2.12.5.2. Product Strategy
17.2.12.5.3. Route of Administration Strategy
17.2.13. Merck Millipore
17.2.13.1. Overview
17.2.13.2. Product Portfolio
17.2.13.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.13.4. Sales Footprint
17.2.13.5. Strategy Overview
17.2.13.5.1. Marketing Strategy
17.2.13.5.2. Product Strategy
17.2.13.5.3. Route of Administration Strategy
17.2.14. GeneCopoeia, Inc
17.2.14.1. Overview
17.2.14.2. Product Portfolio
17.2.14.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.14.4. Sales Footprint
17.2.14.5. Strategy Overview
17.2.14.5.1. Marketing Strategy
17.2.14.5.2. Product Strategy
17.2.14.5.3. Route of Administration Strategy
17.2.15. Bioneer Corporation
17.2.15.1. Overview
17.2.15.2. Product Portfolio
17.2.15.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.15.4. Sales Footprint
17.2.15.5. Strategy Overview
17.2.15.5.1. Marketing Strategy
17.2.15.5.2. Product Strategy
17.2.15.5.3. Route of Administration Strategy
17.2.16. Oxford Expression Technologies Ltd
17.2.16.1. Overview
17.2.16.2. Product Portfolio
17.2.16.3. Profitability by Market Segments (Product/Route of Administration/Region)
17.2.16.4. Sales Footprint
17.2.16.5. Strategy Overview
17.2.16.5.1. Marketing Strategy
17.2.16.5.2. Product Strategy
17.2.16.5.3. Route of Administration Strategy
18. Assumptions and Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Protein Expression Technology Market Value (US$ Mn) Growth Comparison
Table 02: Global Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Expression System
Table 03: Global Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product
Table 04: Global Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Application
Table 05: Global Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By End User
Table 06: Global Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Region
Table 07: North America Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Expression System
Table 08: North America Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product
Table 09: North America Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Application
Table 10: North America Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By End User
Table 11: North America Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Country
Table 12: Latin America Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Expression System
Table 13: Latin America Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product
Table 14: North America Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Application
Table 15: Latin America Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By End User
Table 16: Latin America Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Country
Table 17: Western Europe Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Expression System
Table 18: Western Europe Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product
Table 19: Western Europe Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Application
Table 20: Western Europe Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By End User
Table 21: Western Europe Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Country
Table 22: Eastern Europe Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Expression System
Table 23: Eastern Europe Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product
Table 24: Eastern Europe Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Application
Table 25: Eastern Europe Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By End User
Table 26: Eastern Europe Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Country
Table 27: APEJ Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Expression System
Table 28: APEJ Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product
Table 29: APEJ Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Application
Table 30: APEJ Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By End User
Table 31: APEJ Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Country
Table 32: Japan Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Expression System
Table 33: Japan Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product
Table 34: Japan Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Application
Table 35: Japan Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By End User
Table 36: MEA Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Expression System
Table 37: MEA Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By Product
Table 38: MEA Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Application
Table 39: MEA Protein Expression Technology Market Value (US$ Mn) Analysis and Opportunity Assessment 2014–2029, By End User
Table 40: MEA Protein Expression Technology Market Value (US$ Mn) Analysis 2014-2021and Forecast 2022–2029, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Protein Expression Technology Market Value Analysis (US$ Mn), 2014-2021
Figure 02: Global Protein Expression Technology Market Value Forecast (US$ Mn), 2022-2029
Figure 03: Global Protein Expression Technology Market Absolute $ Opportunity, 2022 - 2029
Figure 04: Comparison October 2020 and October 2022, Y-o-Y Forecast
Figure 05: Global Protein Expression Technology Market Share Analysis (%), By Expression System, 2022 & 2029
Figure 06: Global Protein Expression Technology Market Y-o-Y Analysis (%), By Expression System, 2022-2029
Figure 07: Global Protein Expression Technology Market Attractiveness Analysis by Expression System, 2022-2029
Figure 08: Global Protein Expression Technology Market Share Analysis (%), By Product, 2022 & 2029
Figure 09: Global Protein Expression Technology Market Y-o-Y Analysis (%), By Product, 2022-2029
Figure 10: Global Protein Expression Technology Market Attractiveness Analysis by Expression System, 2022-2029
Figure 11: Global Protein Expression Technology Market Share Analysis (%), By Application, 2022 & 2029
Figure 12: Global Protein Expression Technology Market Y-o-Y Analysis (%), By Application, 2022-2029
Figure 13: Global Protein Expression Technology Market Attractiveness Analysis by Application, 2022-2029
Figure 14: Global Protein Expression Technology Market Share Analysis (%), By End User, 2022 & 2029
Figure 15: Global Protein Expression Technology Market Y-o-Y Analysis (%), By End User, 2022-2029
Figure 16: Global Protein Expression Technology Market Attractiveness Analysis by End User, 2022-2029
Figure 17: Global Protein Expression Technology Market Share Analysis (%), By Country, 2022 & 2029
Figure 18: Global Protein Expression Technology Market Y-o-Y Analysis (%), By Country, 2022-2029
Figure 19: Global Protein Expression Technology Market Attractiveness Analysis by Country, 2022-2029
Figure 20: North America Protein Expression Technology Market Value Share By Expression System (2022)
Figure 21: North America Protein Expression Technology Market Value Share By Product (2022)
Figure 22: North America Protein Expression Technology Market Value Share By Application (2022)
Figure 23: North America Protein Expression Technology Market Value Share By End User (2022)
Figure 24: North America Protein Expression Technology Market Value Share By Country (2022)
Figure 25: North America Protein Expression Technology Market Value Analysis (US$ Mn), 2014-2021
Figure 26: North America Protein Expression Technology Market Value Forecast (US$ Mn), 2022-2029
Figure 27: North America Protein Expression Technology Market Attractiveness Analysis by Expression System, 2022-2029
Figure 28: North America Protein Expression Technology Market Attractiveness Analysis by Product, 2022-2029
Figure 29: North America Protein Expression Technology Market Attractiveness Analysis by Application, 2022-2029
Figure 30: North America Protein Expression Technology Market Attractiveness Analysis by End User, 2022-2029
Figure 31: North America Protein Expression Technology Market Attractive Analysis By Country, 2022-2029
Figure 32: Latin America Protein Expression Technology Market Value Share By Expression System (2022)
Figure 33: Latin America Protein Expression Technology Market Value Share By Product (2022)
Figure 34: Latin America Protein Expression Technology Market Value Share By Application (2022)
Figure 35: Latin America Protein Expression Technology Market Value Share By End User (2022)
Figure 36: Latin America Protein Expression Technology Market Value Share By Country (2022)
Figure 37: Latin America Protein Expression Technology Market Value Analysis (US$ Mn), 2014-2021
Figure 38: Latin America Protein Expression Technology Market Value Forecast (US$ Mn), 2022-2029
Figure 39: Latin America Protein Expression Technology Market Attractiveness Analysis by Expression System, 2022-2029
Figure 40: Latin America Protein Expression Technology Market Attractiveness Analysis by Product, 2022-2029
Figure 41: Latin America Protein Expression Technology Market Attractiveness Analysis by Application, 2022-2029
Figure 42: Latin America Protein Expression Technology Market Attractiveness Analysis by End User, 2022-2029
Figure 43: Latin America Protein Expression Technology Market Attractive Analysis By Country, 2022-2029
Figure 44: Western Europe Protein Expression Technology Market Value Share By Expression System (2022)
Figure 45: Western Europe Protein Expression Technology Market Value Share By Product (2022)
Figure 46: Western Europe Protein Expression Technology Market Value Share By Application (2022)
Figure 47: Western Europe Protein Expression Technology Market Value Share By End User (2022)
Figure 48: Western Europe Protein Expression Technology Market Value Share By Country (2022)
Figure 49: Western Europe Protein Expression Technology Market Value Analysis (US$ Mn), 2014-2021
Figure 50: Western Europe Protein Expression Technology Market Value Forecast (US$ Mn), 2022-2029
Figure 51: Western Europe Protein Expression Technology Market Attractiveness Analysis by Expression System, 2022-2029
Figure 52: Western Europe Protein Expression Technology Market Attractiveness Analysis by Product, 2022-2029
Figure 53: Western Europe Protein Expression Technology Market Attractiveness Analysis by Application, 2022-2029
Figure 54: Western Europe Protein Expression Technology Market Attractiveness Analysis by End User, 2022-2029
Figure 55: Western Europe Protein Expression Technology Market Attractive Analysis By Country, 2022-2029
Figure 56: Eastern Europe Protein Expression Technology Market Value Share By Expression System (2022)
Figure 57: Eastern Europe Protein Expression Technology Market Value Share By Product (2022)
Figure 58: Eastern Europe Protein Expression Technology Market Value Share By Application (2022)
Figure 59: Eastern Europe Protein Expression Technology Market Value Share By End User (2022)
Figure 60: Eastern Europe Protein Expression Technology Market Value Share By Country (2022)
Figure 61: Eastern Europe Protein Expression Technology Market Value Analysis (US$ Mn), 2014-2021
Figure 62: Eastern Europe Protein Expression Technology Market Value Forecast (US$ Mn), 2022-2029
Figure 63: Eastern Europe Protein Expression Technology Market Attractiveness Analysis by Expression System, 2022-2029
Figure 64: Eastern Europe Protein Expression Technology Market Attractiveness Analysis by Product, 2022-2029
Figure 65: Eastern Europe Protein Expression Technology Market Attractiveness Analysis by Application, 2022-2029
Figure 66: Eastern Europe Protein Expression Technology Market Attractiveness Analysis by End User, 2022-2029
Figure 67: Eastern Europe Protein Expression Technology Market Attractive Analysis By Country, 2022-2029
Figure 68: APEJ Protein Expression Technology Market Value Share By Expression System (2022)
Figure 69: APEJ Protein Expression Technology Market Value Share By Product (2022)
Figure 70: APEJ Protein Expression Technology Market Value Share By Application (2022)
Figure 71: APEJ Protein Expression Technology Market Value Share By End User (2022)
Figure 72: APEJ Protein Expression Technology Market Value Share By Country (2022)
Figure 73: APEJ Protein Expression Technology Market Value Analysis (US$ Mn), 2014-2021
Figure 74: APEJ Protein Expression Technology Market Value Forecast (US$ Mn), 2022-2029
Figure 75: APEJ Protein Expression Technology Market Attractiveness Analysis by Expression System, 2022-2029
Figure 76: APEJ Protein Expression Technology Market Attractiveness Analysis by Product, 2022-2029
Figure 77: APEJ Protein Expression Technology Market Attractiveness Analysis by Application, 2022-2029
Figure 78: APEJ Protein Expression Technology Market Attractiveness Analysis by End User, 2022-2029
Figure 79: APEJ Protein Expression Technology Market Attractive Analysis By Country, 2022-2029
Figure 80: Japan Protein Expression Technology Market Value Share By Expression System (2022)
Figure 81: Japan Protein Expression Technology Market Value Share By Product (2022)
Figure 82: Japan Protein Expression Technology Market Value Share By Application (2022)
Figure 83: Japan Protein Expression Technology Market Value Share By End User (2022)
Figure 84: Japan Protein Expression Technology Market Value Analysis (US$ Mn), 2014-2021
Figure 85: Japan Protein Expression Technology Market Value Forecast (US$ Mn), 2022-2029
Figure 86: Japan Protein Expression Technology Market Attractiveness Analysis by Expression System, 2022-2029
Figure 87: Japan Protein Expression Technology Market Attractiveness Analysis by Product, 2022-2029
Figure 88: Japan Protein Expression Technology Market Attractiveness Analysis by Application, 2022-2029
Figure 89: APEJ Protein Expression Technology Market Attractiveness Analysis by End User, 2022-2029
Figure 90: MEA Protein Expression Technology Market Value Share By Expression System (2022)
Figure 91: MEA Protein Expression Technology Market Value Share By Product (2022)
Figure 92: MEA Protein Expression Technology Market Value Share By Application (2022)
Figure 93: MEA Protein Expression Technology Market Value Share By End User (2022)
Figure 94: MEA Protein Expression Technology Market Value Share By Country (2022)
Figure 95: Middle East & Africa Protein Expression Technology Market Value Analysis (US$ Mn), 2014-2021
Figure 96: Middle East & Africa Protein Expression Technology Market Value Forecast (US$ Mn), 2022-2029
Figure 97: MEA Protein Expression Technology Market Attractiveness Analysis by Expression System, 2022-2029
Figure 98: MEA Protein Expression Technology Market Attractiveness Analysis by Product, 2022-2029
Figure 99: MEA Protein Expression Technology Market Attractiveness Analysis by Application, 2022-2029
Figure 100: MEA Protein Expression Technology Market Attractiveness Analysis by End User, 2022-2029
Figure 101: MEA Protein Expression Technology Market Attractive Analysis By Country, 2022-2029
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
